Back to Results
First PageMeta Content
Medicine / CYP3A4 / Drug metabolism / CYP3A / CYP2D6 / Metabolism / CYP2A6 / Xenobiotic / CYP1B1 / Cytochrome P450 / Biology / Chemistry


1 TE Chandra Prakash and Alfin D. N. Vaz RI
Add to Reading List

Document Date: 2008-10-21 05:02:06

Open Document

File Size: 250,85 KB

Share Result on Facebook

Company

Amino / Pfizer Inc. / USA CO / Wen Xie C 2009 John Wiley & Sons Inc. / /

Currency

pence / USD / /

Event

FDA Phase / /

IndustryTerm

treatment of depressive disorders / pharmaceutical development / treatment of hormone-mediated cancer / human and animal hepatic cellular and subcellular systems / treatment of Parkinson’s disease / chemical entities / foreign chemicals / /

MedicalCondition

tumor / depressive disorders / tissue injury / hormone-mediated cancer / Parkinson’s disease / human pulmonary microsomes / inherited deficiency / /

Organization

RI AL / MA Department of Pharmacokinetics / /

Person

AL DRUG METABOLISM / /

Position

Prime Minister / /

Product

diazepam / propofol / clozapine / phenytoin / S-9 / acetaminophen / glipizide / estradiol / tolbutamide / ranitidine / theophylline / ketoprofen / sulindac / ibuprofen / paclitaxel / chlorzoxazone / cyclophosphamide / testosterone / famciclovir / carbamazepine / lidocaine / riluzole / methimazole / glycine / zonisamide / ketoconazole / ifosfamide / triazolam / erythromycin / cimetidine / omeprazole / nifedipine / piroxicam / losartan / mitomycin / dapsone / nicotine / zaleplon / metabolism / CYP2C19 / P450 / CYP2F1 / /

Technology

Pharmacokinetics / drug metabolism / biotransformations / UDP / drug development / /

SocialTag